- Home
- MESO vs PDM Comparison
MESO vs PDM Comparison
Compare MESO & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MESO | PDM |
|---|---|---|
| Founded | 2004 | 1997 |
| Country | Australia | United States |
| Employees | 108 | 140 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.2B |
| IPO Year | 2005 | 1997 |
Fundamental Metrics
Financial Performance| Metric | MESO | PDM |
|---|---|---|
| Price | $15.48 | $9.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 177.2K | ★ 966.9K |
| Earning Date | 02-26-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $564,994,000.00 |
| Revenue This Year | $629.74 | $4.21 |
| Revenue Next Year | $30.65 | $1.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.05 | $6.32 |
| 52 Week High | $21.50 | $10.13 |
Technical Indicators
Market Signals| Indicator | MESO | PDM |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 45.05 |
| Support Level | $15.37 | $9.41 |
| Resistance Level | $16.06 | $9.97 |
| Average True Range (ATR) | 0.42 | 0.22 |
| MACD | -0.22 | -0.03 |
| Stochastic Oscillator | 1.74 | 10.74 |
Price Performance
Historical ComparisonAbout MESO Mesoblast Limited
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.